Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Bio-Techne's operating assets for the quarter that ended in Mar. 2026 was MXN42,211 Mil. Bio-Techne's operating liabilities for the quarter that ended in Mar. 2026 was MXN3,155 Mil. Bio-Techne's Total Assets for the quarter that ended in Dec. 2025 was MXN45,423 Mil. Therefore, Bio-Techne's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.86.
Bio-Techne Scaled Net Operating Assets Related Terms
Bio-Techne Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Bio-Techne's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TECH vs HALO, IBRX, NUVL: Scaled Net Operating Assets Comparison
For the Biotechnology subindustry, Bio-Techne's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Scaled Net Operating Assets vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.86 mean?
Bio-Techne (MEX:TECH) has a Scaled Net Operating Assets of 0.86 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Scaled Net Operating Assets too high?
Bio-Techne's current Scaled Net Operating Assets is 0.86. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Scaled Net Operating Assets compare to HALO and IBRX?
Bio-Techne's Scaled Net Operating Assets of 0.86 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bio-Techne and its competitors. Bio-Techne's current Scaled Net Operating Assets is 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Scaled Net Operating Assets of 0.86. The stock's GF Value™ is MXN1,112.56, compared to a current price of MXN1,090.00 — trading 2% below its estimated fair value. The current Scaled Net Operating Assets is 0.86. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Scaled Net Operating Assets is 0.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of MXN1,090.00 is trading 2% below its estimated GF Value™ of MXN1,112.56.
Key valuation signals for MEX:TECH:
Scaled Net Operating Assets: 0.86
GF Value™: MXN1,112.56 vs. price of MXN1,090.00 (2% below fair value)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score
Get the complete analysis for MEX:TECH
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
